Senior Principal Scientist
Johnson & Johnson
Raj Kurupati, Ph.D.
Dr. Raj Kurupati is a Senior Principal Scientist at Johnson & Johnson Innovative Medicine, with a proven track record in immuno-oncology, cell therapy, and translational research. With over a decade of experience, he specializes in developing and optimizing cellular immunotherapies, biomarker strategies, and immune monitoring assays.
Dr. Kurupati has led numerous projects focused on understanding immune phenotypes, evaluating drug resistance mechanisms, and advancing novel therapeutic approaches for cancer and infectious diseases. His expertise includes cell therapy, vaccine development, flow cytometry, and molecular biology, contributing significantly to clinical and preclinical research initiatives.
He holds a Ph.D. in Biomedical Sciences from the University of Delhi and has published extensively in high-impact journals. Throughout his career, Dr. Kurupati has presented his research at numerous national and international conferences, sharing insights on immunometabolism, vaccine responses, and cell therapy innovations.